AT1 4.55% 2.3¢ atomo diagnostics limited

AT1 FY21 - General Discussion + FA, page-303

  1. 1,209 Posts.
    lightbulb Created with Sketch. 646
    @JVDW
    Thanks for the quick, detailed answer. It sounds logical and would fit into AT1's natural growth plans for global markets, gov health body connections etc

    I would have thought M&A would be much further 5-10yr future possibility, considering AT1 is still such a minnow...however what you say also seems quite logical - lots of healthcare companies will be cashed up and wanting to M&A with proven IP, proven Covid19 rev and market share

    I feel like AT1 CEO might not sell out, considering his baby is finally arriving on the world stage...but I guess never say never for anything in the biz world......agreed though, if AT1's growth is proven, it will certainly attract more attention.

    I'll put M&A on my to-research list for healthcare SmallCap stocks. Ironically, I know more M&A stuff about large cap pharma, milk and EV companies than this end of town...something I need improve on. thanks for the lead!
    Last edited by FinFree101: 10/11/20
 
watchlist Created with Sketch. Add AT1 (ASX) to my watchlist
(20min delay)
Last
2.3¢
Change
0.001(4.55%)
Mkt cap ! $14.70M
Open High Low Value Volume
2.3¢ 2.3¢ 2.3¢ $1.039K 45.19K

Buyers (Bids)

No. Vol. Price($)
5 224074 2.2¢
 

Sellers (Offers)

Price($) Vol. No.
2.4¢ 165930 3
View Market Depth
Last trade - 11.58am 09/08/2024 (20 minute delay) ?
AT1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.